Acute prolymphocytic leukaemia (APL) treatment update

This webinar will explore how acute promyelocytic leukaemia (APL) is treated today and what is on the horizon: how is a therapy chosen, how is prognosis determined and what level of involvement should patients expect in their care decisions.

This webinar will explore how acute promyelocytic leukaemia (APL) is treated today and what is on the horizon: how is a therapy chosen, how is prognosis determined and what level of involvement should patients expect in their care decisions.

We’ll also explain the different types of intensive and non-intensive treatments, who can have a particular therapy, how they work, their efficacy and side effects.

Dr Amit Patel (Consultant in Cellular Therapies and Stem Cell Transplantation, Haematology Oncology and Intensive Care Medicine at the Christie NHS Foundation Trust) will be leading our webinar, and he will also be joined by a clinical nurse specialist and an APL patient to explore topics together and answer your questions during the discussion.

Webinar details

Date: Wednesday 3rd March 2021

Time: 9:30am

Topic: Acute promyelocytic leukaemia (APL) treatment update

Host: Leukaemia Care

How do I join the webinar? 

The webinar is being hosted on Zoom and Facebook, meaning you can choose a platform to suit you. Zoom is the best place to ask questions, but if you join via Facebook we will try and get all the questions sent over to our panel; however, please expect a delay.

Information on how to join via Zoom or Facebook is below. 

Watch via Zoom

To join via Zoom, all you need to do is register your attendance before the webinar starts. You will then receive an email inviting you to join the webinar on the day.

Watch via Facebook

To join via Facebook, all you need is a Facebook account. Once logged in head to Leukaemia Care’s Facebook page at 9:30am on 3rd March and find the live video (it will be at the top of our feed).

Register your place via zoom here. 

Head to Leukaemia Care’s Facebook page at 9:30am on the day via this link: www.facebook.com/leukaemiacare>

Please note, we will not be able to give individual medical advice. You will be directed to your own clinical team if we cannot answer your question in the webinar.

Due to the large amount of registrants, we cannot guarantee that everyone’s questions will be answered, but we will try and do our best in the time frame that we have.

If you have any issues registering via Zoom or issues on the day, please get in touch by emailing advocacy@leukaemiacare.org.uk.

Book Now

T-cell Acute Lymphoblastic Leukaemia

T-cell acute lymphoblastic leukaemia (T-ALL) is a specific type of leukaemia. It is a variant of acute lymphoblastic leukaemia (ALL), with features similar to some types of lymphoma.

Read More